MGD014
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MGD014, covering 2022-09-02 to 2025-03-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy [Phase 1]